NCT04973228 - Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM) | Biotech Hunter

Enrollment

457

Participants

Timeline

Start Date

July 8, 2021

Primary Completion Date

April 6, 2022

Study Completion Date

April 6, 2022

Conditions

Seborrheic Dermatitis

Interventions

DRUG

Roflumilast Foam

Roflumilast 0.3% foam for topical application

DRUG

Vehicle Foam

Vehicle foam for topical application

Trial Locations (53)

10065

Arcutis Biotherapeutics Clinical Site 66, New York

10462

Arcutis Biotherapeutics Clinical Site 63, The Bronx

15213

Arcutis Biotherapeutics Clinical Site 27, Pittsburgh

19008

Arcutis Biotherapeutics Clinical Site 08, Broomall

20850

Arcutis Biotherapeutics Clinical Site 02, Rockville

Arcutis Biotherapeutics Clinical Site 28, Rockville

23502

Arcutis Biotherapeutics Clinical Site 17, Norfolk

27104

Arcutis Biotherapeutics Clinical Site 70, Winston-Salem

27262

Arcutis Biotherapeutics Clinical Site 23, High Point

32771

Arcutis Biotherapeutics Clinical Site 65, Sanford

33134

Arcutis Biotherapeutics Clinical Site 42, Coral Gables

33162

Arcutis Biotherapeutics Clinical Site 31, North Miami Beach

33484

Arcutis Biotherapeutics Clinical Site 57, Delray Beach

33613

Arcutis Biotherapeutics Clinical Site 12, Tampa

33770

Arcutis Biotherapeutics Clinical Site 33, Largo

37922

Arcutis Biotherapeutics Clinical Site 06, Knoxville

40217

Arcutis Biotherapeutics Clinical Site 15, Louisville

43209

Arcutis Biotherapeutics Clinical Site 18, Bexley

46168

Arcutis Biotherapeutics Clinical Site 22, Plainfield

46250

Arcutis Biotherapeutics Clinical Site 03, Indianapolis

48038

Arcutis Biotherapeutics Clinical Site 40, Clinton Township

48202

Arcutis Biotherapeutics Clinical Site 20, Detroit

55432

Arcutis Biotherapeutics Clinical Site 14, Fridley

60008

Arcutis Biotherapeutics Clinical Site 10, Rolling Meadows

64506

Arcutis Biotherapeutics Clinical Site 44, Saint Joseph

70605

Arcutis Biotherapeutics Clinical Site 04, Lake Charles

75024

Arcutis Biotherapeutics Clinical Site 72, Plano

76011

Arcutis Biotherapeutics Clinical Site 13, Arlington

77030

Arcutis Biotherapeutics Clinical Site 60, Houston

77845

Arcutis Biotherapeutics Clinical Site 41, College Station

78213

Arcutis Biotherapeutics Clinical Site 54, San Antonio

78218

Arcutis Biotherapeutics Clinical Site 24, San Antonio

78660

Arcutis Biotherapeutics Clinical Site 26, Pflugerville

78759

Arcutis Biotherapeutics Clinical Site 11, Austin

84088

Arcutis Biotherapeutics Clinical Site 07, West Jordan

85255

Arcutis Biotherapeutics Clinical Site 01, Scottsdale

89509

Arcutis Biotherapeutics Clinical Site 19, Reno

90404

Arcutis Biotherapeutics Clinical Site 21, Santa Monica

92024

Arcutis Biotherapeutics Clinical Site 45, Encinitas

92123

Arcutis Biotherapeutics Clinical Site 46, San Diego

Arcutis Biotherapeutics Clinical Site 64, San Diego

97223

Arcutis Biotherapeutics Clinical Site 71, Portland

08520

Arcutis Biotherapeutics Clinical Site 34, East Windsor

T2J 7E1

Arcutis Biotherapeutics Clinical Site 35, Calgary

V3V 0C6

Arcutis Biotherapeutics Clinical Site 37, Surrey

R3M 3Z4

Arcutis Biotherapeutics Clinical Site 47, Winnipeg

E3B 1G9

Arcutis Biotherapeutics Clinical Site 43, Fredericton

N6H 5L5

Arcutis Biotherapeutics Clinical Site 16, London

L5H 1G9

Arcutis Biotherapeutics Clinical Site 29, Mississauga

P1B 3Z7

Arcutis Biotherapeutics Clinical Site 30, North Bay

K9J 5K2

Arcutis Biotherapeutics Clinical Site 32, Peterborough

N2J 1C4

Arcutis Biotherapeutics Clinical Site 36, Waterloo

H3Z 2S6

Arcutis Biotherapeutics Clinical Site 09, Westmount